Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 11 |
GO:0030684 | preribosome | 3 | 2 |
GO:0030687 | preribosome, large subunit precursor | 4 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0034399 | nuclear periphery | 2 | 2 |
GO:0043226 | organelle | 2 | 11 |
GO:0043228 | non-membrane-bounded organelle | 3 | 11 |
GO:0043229 | intracellular organelle | 3 | 11 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:1990904 | ribonucleoprotein complex | 2 | 2 |
Related structures:
AlphaFold database: E9AF03
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006364 | rRNA processing | 8 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0016072 | rRNA metabolic process | 7 | 2 |
GO:0022613 | ribonucleoprotein complex biogenesis | 4 | 11 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0042273 | ribosomal large subunit biogenesis | 5 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044085 | cellular component biogenesis | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:0042254 | ribosome biogenesis | 5 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 46 | 50 | PF00656 | 0.718 |
CLV_C14_Caspase3-7 | 71 | 75 | PF00656 | 0.532 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.504 |
CLV_NRD_NRD_1 | 184 | 186 | PF00675 | 0.292 |
CLV_NRD_NRD_1 | 219 | 221 | PF00675 | 0.311 |
CLV_NRD_NRD_1 | 223 | 225 | PF00675 | 0.286 |
CLV_NRD_NRD_1 | 8 | 10 | PF00675 | 0.508 |
CLV_PCSK_FUR_1 | 207 | 211 | PF00082 | 0.338 |
CLV_PCSK_FUR_1 | 220 | 224 | PF00082 | 0.320 |
CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.503 |
CLV_PCSK_KEX2_1 | 120 | 122 | PF00082 | 0.292 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.301 |
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.506 |
CLV_PCSK_KEX2_1 | 184 | 186 | PF00082 | 0.291 |
CLV_PCSK_KEX2_1 | 209 | 211 | PF00082 | 0.285 |
CLV_PCSK_KEX2_1 | 222 | 224 | PF00082 | 0.306 |
CLV_PCSK_KEX2_1 | 244 | 246 | PF00082 | 0.408 |
CLV_PCSK_KEX2_1 | 263 | 265 | PF00082 | 0.317 |
CLV_PCSK_KEX2_1 | 270 | 272 | PF00082 | 0.629 |
CLV_PCSK_PC1ET2_1 | 10 | 12 | PF00082 | 0.503 |
CLV_PCSK_PC1ET2_1 | 120 | 122 | PF00082 | 0.292 |
CLV_PCSK_PC1ET2_1 | 148 | 150 | PF00082 | 0.320 |
CLV_PCSK_PC1ET2_1 | 209 | 211 | PF00082 | 0.285 |
CLV_PCSK_PC1ET2_1 | 222 | 224 | PF00082 | 0.301 |
CLV_PCSK_PC1ET2_1 | 244 | 246 | PF00082 | 0.445 |
CLV_PCSK_PC1ET2_1 | 263 | 265 | PF00082 | 0.322 |
CLV_PCSK_PC7_1 | 205 | 211 | PF00082 | 0.301 |
CLV_PCSK_SKI1_1 | 100 | 104 | PF00082 | 0.290 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.540 |
CLV_PCSK_SKI1_1 | 185 | 189 | PF00082 | 0.300 |
CLV_PCSK_SKI1_1 | 241 | 245 | PF00082 | 0.412 |
CLV_Separin_Metazoa | 200 | 204 | PF03568 | 0.301 |
DEG_SPOP_SBC_1 | 102 | 106 | PF00917 | 0.320 |
DOC_CKS1_1 | 249 | 254 | PF01111 | 0.412 |
DOC_CYCLIN_RxL_1 | 9 | 19 | PF00134 | 0.571 |
DOC_PP1_RVXF_1 | 86 | 92 | PF00149 | 0.412 |
DOC_PP4_FxxP_1 | 91 | 94 | PF00568 | 0.301 |
DOC_USP7_MATH_1 | 102 | 106 | PF00917 | 0.303 |
DOC_USP7_MATH_1 | 243 | 247 | PF00917 | 0.362 |
DOC_USP7_MATH_1 | 65 | 69 | PF00917 | 0.749 |
DOC_USP7_UBL2_3 | 188 | 192 | PF12436 | 0.301 |
DOC_USP7_UBL2_3 | 263 | 267 | PF12436 | 0.373 |
DOC_WW_Pin1_4 | 248 | 253 | PF00397 | 0.373 |
DOC_WW_Pin1_4 | 29 | 34 | PF00397 | 0.755 |
LIG_14-3-3_CanoR_1 | 100 | 110 | PF00244 | 0.315 |
LIG_14-3-3_CanoR_1 | 135 | 140 | PF00244 | 0.344 |
LIG_14-3-3_CanoR_1 | 184 | 188 | PF00244 | 0.393 |
LIG_FHA_1 | 104 | 110 | PF00498 | 0.301 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.398 |
LIG_FHA_1 | 249 | 255 | PF00498 | 0.347 |
LIG_FHA_2 | 85 | 91 | PF00498 | 0.388 |
LIG_LIR_Apic_2 | 90 | 94 | PF02991 | 0.322 |
LIG_LIR_Gen_1 | 151 | 162 | PF02991 | 0.288 |
LIG_NRP_CendR_1 | 270 | 273 | PF00754 | 0.660 |
LIG_PCNA_yPIPBox_3 | 220 | 233 | PF02747 | 0.445 |
LIG_SH2_NCK_1 | 4 | 8 | PF00017 | 0.528 |
LIG_SH2_SRC | 4 | 7 | PF00017 | 0.601 |
LIG_SH2_SRC | 47 | 50 | PF00017 | 0.745 |
LIG_SH2_STAP1 | 154 | 158 | PF00017 | 0.301 |
LIG_SH2_STAP1 | 4 | 8 | PF00017 | 0.460 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.745 |
LIG_SH3_3 | 59 | 65 | PF00018 | 0.643 |
LIG_SUMO_SIM_par_1 | 129 | 134 | PF11976 | 0.353 |
LIG_TRAF2_1 | 50 | 53 | PF00917 | 0.744 |
MOD_CDK_SPK_2 | 248 | 253 | PF00069 | 0.373 |
MOD_CDK_SPxxK_3 | 248 | 255 | PF00069 | 0.373 |
MOD_CK1_1 | 105 | 111 | PF00069 | 0.323 |
MOD_CK2_1 | 135 | 141 | PF00069 | 0.308 |
MOD_CK2_1 | 183 | 189 | PF00069 | 0.386 |
MOD_CK2_1 | 29 | 35 | PF00069 | 0.722 |
MOD_CK2_1 | 47 | 53 | PF00069 | 0.706 |
MOD_CK2_1 | 65 | 71 | PF00069 | 0.721 |
MOD_CK2_1 | 84 | 90 | PF00069 | 0.364 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.316 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.398 |
MOD_N-GLC_1 | 225 | 230 | PF02516 | 0.445 |
MOD_NEK2_1 | 101 | 106 | PF00069 | 0.301 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.353 |
MOD_NEK2_1 | 171 | 176 | PF00069 | 0.328 |
MOD_NEK2_1 | 212 | 217 | PF00069 | 0.412 |
MOD_PKA_2 | 183 | 189 | PF00069 | 0.404 |
MOD_Plk_4 | 126 | 132 | PF00069 | 0.321 |
MOD_ProDKin_1 | 248 | 254 | PF00069 | 0.373 |
MOD_ProDKin_1 | 29 | 35 | PF00069 | 0.754 |
MOD_SUMO_for_1 | 119 | 122 | PF00179 | 0.301 |
MOD_SUMO_rev_2 | 236 | 246 | PF00179 | 0.440 |
TRG_ENDOCYTIC_2 | 154 | 157 | PF00928 | 0.285 |
TRG_ER_diArg_1 | 15 | 18 | PF00400 | 0.603 |
TRG_ER_diArg_1 | 202 | 205 | PF00400 | 0.301 |
TRG_ER_diArg_1 | 252 | 255 | PF00400 | 0.361 |
TRG_ER_diArg_1 | 270 | 273 | PF00400 | 0.617 |
TRG_NLS_Bipartite_1 | 209 | 226 | PF00514 | 0.301 |
TRG_NLS_MonoCore_2 | 219 | 224 | PF00514 | 0.303 |
TRG_NLS_MonoCore_2 | 8 | 13 | PF00514 | 0.488 |
TRG_NLS_MonoExtC_3 | 219 | 224 | PF00514 | 0.324 |
TRG_NLS_MonoExtN_4 | 220 | 226 | PF00514 | 0.301 |
TRG_NLS_MonoExtN_4 | 241 | 248 | PF00514 | 0.445 |
TRG_NLS_MonoExtN_4 | 9 | 14 | PF00514 | 0.486 |
TRG_Pf-PMV_PEXEL_1 | 107 | 112 | PF00026 | 0.344 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I326 | Leptomonas seymouri | 74% | 100% |
A0A0S4IQU9 | Bodo saltans | 58% | 100% |
A0A1X0P5U9 | Trypanosomatidae | 73% | 100% |
A0A3Q8IPE1 | Leishmania donovani | 95% | 100% |
A0A3R7KIH6 | Trypanosoma rangeli | 68% | 100% |
A4HMK3 | Leishmania braziliensis | 86% | 100% |
A4IB82 | Leishmania infantum | 95% | 100% |
C9ZZK7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
E9B659 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
O13802 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 34% | 82% |